# FDA Inspection 1274604 - Granules Pharmaceuticals Inc. - June 27, 2025

Source: https://www.keypedia.com/records/fda_inspections/granules-pharmaceuticals-inc/c26a7eea-057c-452e-9446-c4409110a57b
Source feed: FDA_Inspections

> FDA Inspection 1274604 for Granules Pharmaceuticals Inc. on June 27, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1274604
- Company Name: Granules Pharmaceuticals Inc.
- Inspection Date: 2025-06-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Office Name: Baltimore District Office

## Related Documents

- [FDA Inspection 1225087 - 2023-12-15](https://www.keypedia.com/records/fda_inspections/granules-pharmaceuticals-inc/45371d19-7a67-4bab-ae38-48217349ea87)
- [FDA Inspection 1215034 - 2023-08-03](https://www.keypedia.com/records/fda_inspections/granules-pharmaceuticals-inc/f3a55b08-5f7e-4034-af92-ce1868eb2476)
- [FDA Inspection 1175097 - 2022-07-22](https://www.keypedia.com/records/fda_inspections/granules-pharmaceuticals-inc/d7966f15-715b-4405-88ac-c9e7d0d9e64c)
- [FDA Inspection 1035023 - 2017-12-08](https://www.keypedia.com/records/fda_inspections/granules-pharmaceuticals-inc/365993a1-7a71-474c-9726-9ded32a3e0ca)

Company: https://www.keypedia.com/companies/granules-pharmaceuticals-inc/fa93bf3f-822e-47be-9e47-59b1c5446629

Office: https://www.keypedia.com/offices/baltimore-district-office/6be371ff-03e9-4039-999c-ff170f17a9fa